Health
Diabetes treatment may protect against COVID-19 mortality – Medical News Today
A study involving a diverse patient population suggests that a diabetes drug, metformin, may help reduce the risk of COVID-19 mortality.
A critical area of COVID-19 research has focused on the risk factors that may make a person more likely to either get a SARS-CoV-2 infection or die from COVID-19 if they develop it.
SARS-CoV-2 is a novel coronavirus, and while it bears some similarities to other coronaviruses, there is still much that researchers are yet to uncover about how and why it affects some people more than others and how to mitigate the risks.
Studies have begun to emerge demonstrating associations between specific health…
-
Noosa News13 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General5 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General17 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Business22 hours agoTop brokers name 3 ASX shares to buy next week 5 October 2025